Smith DC - Search Results

1

Castration remains despite decreasing definitive treatment of localized prostate cancer in the elderly: A case for de-implementation.

Skolarus TA, Caram ME, Chapman CH, Smith DC, Hollenbeck BK, Hawley S, Tsodikov A, Sales A, Wittmann D, Zaslavsky A. Skolarus TA, et al. Among authors: smith dc. Cancer. 2018 Oct 15;124(20):3971-3974. doi: 10.1002/cncr.31665. Epub 2018 Sep 7. Cancer. 2018. PMID: 30192374 Free PMC article. No abstract available.

2

Rapid ("warm") autopsy study for procurement of metastatic prostate cancer.

Rubin MA, Putzi M, Mucci N, Smith DC, Wojno K, Korenchuk S, Pienta KJ. Rubin MA, et al. Among authors: smith dc. Clin Cancer Res. 2000 Mar;6(3):1038-45. Clin Cancer Res. 2000. PMID: 10741732

3

Expression of nuclear antigen Ki-67 in prostate cancer needle biopsy and radical prostatectomy specimens.

Mucci NR, Rubin MA, Strawderman MS, Montie JE, Smith DC, Pienta KJ. Mucci NR, et al. Among authors: smith dc. J Natl Cancer Inst. 2000 Dec 6;92(23):1941-2. doi: 10.1093/jnci/92.23.1941. J Natl Cancer Inst. 2000. PMID: 11106686 No abstract available.

4

Chemotherapy in patients with prostate specific antigen-only disease after primary therapy for prostate carcinoma: a phase II trial of oral estramustine and oral etoposide.

Munshi HG, Pienta KJ, Smith DC. Munshi HG, et al. Among authors: smith dc. Cancer. 2001 Jun 1;91(11):2175-80. doi: 10.1002/1097-0142(20010601)91:11<2175::aid-cncr1246>3.0.co;2-d. Cancer. 2001. PMID: 11391599 Free article. Clinical Trial.

5

Chemotherapy for localized, high-risk prostate cancer.

Narayan S, Smith DC, Sandler HM. Narayan S, et al. Among authors: smith dc. Semin Radiat Oncol. 2003 Apr;13(2):152-7. doi: 10.1053/srao.2003.50012. Semin Radiat Oncol. 2003. PMID: 12728444 Review.

6

Phase II trial of paclitaxel, estramustine, etoposide, and carboplatin in the treatment of patients with hormone-refractory prostate carcinoma.

Smith DC, Chay CH, Dunn RL, Fardig J, Esper P, Olson K, Pienta KJ. Smith DC, et al. Cancer. 2003 Jul 15;98(2):269-76. doi: 10.1002/cncr.11494. Cancer. 2003. PMID: 12872344 Free article. Clinical Trial.

7

Phase II trial of oral cyclophosphamide, prednisone, and diethylstilbestrol for androgen-independent prostate carcinoma.

Hellerstedt B, Pienta KJ, Redman BG, Esper P, Dunn R, Fardig J, Olson K, Smith DC. Hellerstedt B, et al. Among authors: smith dc. Cancer. 2003 Oct 15;98(8):1603-10. doi: 10.1002/cncr.11686. Cancer. 2003. PMID: 14534875 Free article. Clinical Trial.

8

Advances in prostate cancer chemotherapy: a new era begins.

Pienta KJ, Smith DC. Pienta KJ, et al. Among authors: smith dc. CA Cancer J Clin. 2005 Sep-Oct;55(5):300-18; quiz 323-5. doi: 10.3322/canjclin.55.5.300. CA Cancer J Clin. 2005. PMID: 16166075 Free article. Review.

9

Phase II trial of oral uracil/tegafur plus leucovorin in patients with hormone-refractory prostate carcinoma.

Bhandari MS, Pienta KJ, Fardig J, Olson K, Smith DC. Bhandari MS, et al. Among authors: smith dc. Cancer. 2006 Apr 15;106(8):1715-21. doi: 10.1002/cncr.21815. Cancer. 2006. PMID: 16534795 Free article. Clinical Trial.

10

Dose escalation of oral vinorelbine in combination with estramustine in hormone-refractory adenocarcinoma of the prostate.

Mackler NJ, Dunn RL, Hellerstedt B, Cooney KA, Fardig J, Olson K, Pienta KJ, Smith DC. Mackler NJ, et al. Among authors: smith dc. Cancer. 2006 Jun 15;106(12):2617-23. doi: 10.1002/cncr.21927. Cancer. 2006. PMID: 16691618 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,035 results

Search Page